Chris Vellacott

LONDON (Reuters) - Some leading AstraZeneca Plc shareholders were at odds over whether the British drugmaker made the right decision in rejecting Pfizer Inc's final $118 billion bid to buy...

LONDON (Reuters) - Fidelity Worldwide Investment, which holds around 1.2 percent of AstraZeneca has come out in support of the drugs giant's rejection of a $118 takeover bid by Pfizer...

LONDON (Reuters) - British investors have called upon investment banks to stick closer to lock-up agreements on sales of company shares after a major transaction, saying it would ensure more...

LONDON (Reuters) - Royal Bank of Scotland has poached Credit Suisse's Ewen Stevenson for its new finance director, to help restore the health of the part-nationalized bank which lost 8.2...

LONDON (Reuters) - Barclays faces a backlash from shareholders over its decision to raise bonuses despite a fall in profits, with investors increasingly demanding CEO Antony Jenkins give more money...

LONDON (Reuters) - The global financial crisis has strengthened the Church of England's drive for more ethical business practices by making companies and shareholders more receptive to change, according to...